Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 114 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Doumas, Michael  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Stavropoulos, K., Imprialos K. P., Katsiki N., Petidis K., Kamparoudis A., Petras P., et al. (2018).  Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?. J Clin Hypertens (Greenwich). 20(5), 942-948.
Patoulias, D., Papadopoulos C., Stavropoulos K., Zografou I., Doumas M., & Karagiannis A. (2020).  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.. J Clin Hypertens (Greenwich).
Doumas, M., Katsiki N., & Papademetriou V. (2018).  Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?. Angiology. 69(1), 5-9.
R
Reklou, A., Doumas M., Imprialos K., Stavropoulos K., Patoulias D., & Athyros V. G. (2018).  Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?. Open Cardiovasc Med J. 12, 29-40.
Papademetriou, V., Tsioufis C., & Doumas M. (2014).  Renal denervation and Symplicity HTN-3: "Dubium sapientiae initium" (doubt is the beginning of wisdom).. Circ Res. 115(2), 211-4.
Raman, V. K., Tsioufis C., Doumas M., & Papademetriou V. (2017).  Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?. Curr Treat Options Cardiovasc Med. 19(5), 39.
Papademetriou, V., Rashidi A. Adel, Tsioufis C., & Doumas M. (2014).  Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.. Circulation. 129(13), 1440-51.
Doumas, M., Lazaridis A., & Papademetriou V. (2014).  Renal nerve ablation for resistant hypertension: the dust has not yet settled.. J Clin Hypertens (Greenwich). 16(6), 399-400.
Stavropoulos, K., Imprialos K. P., Athyros V. G., & Doumas M. (2018).  Renal resistive index for renovascular hypertension: In the quest of the Holy Grail.. J Clin Hypertens (Greenwich). 20(3), 589-591.
Doumas, M., Faselis C., & Papademetriou V. (2010).  Renal sympathetic denervation and systemic hypertension.. Am J Cardiol. 105(4), 570-6.
Doumas, M., Stavropoulos K., Imprialos K. P., Athyros V. G., & Karagiannis A. (2018).  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?. J Clin Hypertens (Greenwich). 20(4), 634-636.
Papademetriou, V., Doumas M., & Tsioufis C. (2016).  Renal Sympathetic Denervation: Hibernation or Resurrection?. Cardiology. 135(2), 87-97.
Doumas, M., Faselis C., & Papademetriou V. (2011).  Renal sympathetic denervation in hypertension.. Curr Opin Nephrol Hypertens. 20(6), 647-53.
Petidis, K., Anyfanti P., & Doumas M. (2011).  Renal sympathetic denervation: renal function concerns.. Hypertension. 58(4), e19; author reply e20.
Doumas, M., & Douma S. (2010).  Renal sympathetic denervation: the jury is still out.. Lancet. 376(9756), 1878-80.
Kargiotis, K., Athyros V. G., Giouleme O., Katsiki N., Katsiki E., Anagnostis P., et al. (2015).  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.. World J Gastroenterol. 21(25), 7860-8.
Koutsampasopoulos, K., Vogiatzis I., Ziakas A., Papadopoulos C., Imprialos K. P., Stavropoulos K., et al. (2019).  Right Ventricular Function and Sexual Function: Exploring Shadows in Male and Female Patients With Heart Failure.. J Sex Med.
S
Stavropoulos, K., Imprialos K. P., & Doumas M. (2018).  Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension.. J Clin Hypertens (Greenwich). 20(1), 65-68.
Doumas, M., Athyros V., & Papademetriou V. (2015).  Screening for Primary Aldosteronism: Whom and How?. J Clin Hypertens (Greenwich). 17(7), 547-8.
Imprialos, K., Faselis C., Boutari C., Stavropoulos K., Athyros V., Karagiannis A., et al. (2017).  SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.. Curr Pharm Des. 23(10), 1510-1521.
Doumas, M., Anyfanti P., & Bakris G. (2012).  Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective.. J Hypertens. 30(5), 874-6.
Stavropoulos, K., Imprialos K. P., Stavropoulos N., Bouloukou S., Kerpiniotis G., Dimitriadis K., et al. (2018).  Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease.. Cardiovasc Hematol Disord Drug Targets. 18(2), 120-126.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2018).  Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs.. Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
Kokkinos, P., Faselis C., Myers J., Panagiotakos D., & Doumas M. (2013).  Statin and exercise prescription - Authors' reply.. Lancet. 381(9878), 1622-3.
Kokkinos, P., Faselis C., Myers J., Kokkinos J. Peter, Doumas M., Pittaras A., et al. (2014).  Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans.. Am J Hypertens. 27(3), 422-30.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές